These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 12875787)

  • 21. The Future of Arrhythmias and Electrophysiology.
    Albert CM; Stevenson WG
    Circulation; 2016 Jun; 133(25):2687-96. PubMed ID: 27324363
    [No Abstract]   [Full Text] [Related]  

  • 22. Access to and clinical use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology Countries: 2016 Report from the European Heart Rhythm Association.
    Raatikainen MJ; Arnar DO; Merkely B; Camm AJ; Hindricks G
    Europace; 2016 Aug; 18 Suppl 3():iii1-iii79. PubMed ID: 27496955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are complications of implantable defibrillators under-estimated and benefits over-estimated?
    Brignole M
    Europace; 2009 Sep; 11(9):1129-33. PubMed ID: 19578174
    [No Abstract]   [Full Text] [Related]  

  • 24. Prospective trials of implantable cardioverter defibrillators versus drugs: are they addressing the right question?
    Josephson M; Nisam S
    Am J Cardiol; 1996 Apr; 77(10):859-63. PubMed ID: 8623740
    [No Abstract]   [Full Text] [Related]  

  • 25. Innovations in electrophysiology.
    Cohen M
    Cardiol Young; 2009 Nov; 19 Suppl 2():48-53. PubMed ID: 19857350
    [No Abstract]   [Full Text] [Related]  

  • 26. Antiarrhythmic trials: a decade of growth.
    Kanjwal MY
    Indian Heart J; 1998; 50(3):277-84. PubMed ID: 9753848
    [No Abstract]   [Full Text] [Related]  

  • 27. Unresolved issues in implantable cardioverter-defibrillator therapy.
    Mason PK; DiMarco JP
    Cardiol Clin; 2008 Aug; 26(3):433-9, vii. PubMed ID: 18538189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognosis of arrhythmia patients with implantable cardioverter-defibrillator with special reference to heart rate and QRS duration.
    Kawada T
    Int J Cardiol; 2015 Feb; 181():106-7. PubMed ID: 25497530
    [No Abstract]   [Full Text] [Related]  

  • 29. Drug therapy versus implantation of a cardiac defibrillator for the treatment of malignant arrhythmias in left ventricular dysfunction.
    Mannino MM; Mehta D; Langan NM; Gomes JA
    Am Heart J; 1996 Jun; 131(6):1251-9. PubMed ID: 8644621
    [No Abstract]   [Full Text] [Related]  

  • 30. Management of arrhythmias in the emergency department.
    Hood RE; Shorofsky SR
    Cardiol Clin; 2006 Feb; 24(1):125-33, vii. PubMed ID: 16326262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
    Wilkoff BL; Cook JR; Epstein AE; Greene HL; Hallstrom AP; Hsia H; Kutalek SP; Sharma A;
    JAMA; 2002 Dec; 288(24):3115-23. PubMed ID: 12495391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Drug refractory arrhythmia].
    Igawa O; Shigemasa C
    Ryoikibetsu Shokogun Shirizu; 1996; (12):535-7. PubMed ID: 9047532
    [No Abstract]   [Full Text] [Related]  

  • 33. Arrhythmias: drugs and devices.
    Lüscher TF
    Eur Heart J; 2015 Jul; 36(28):1773-5. PubMed ID: 26199429
    [No Abstract]   [Full Text] [Related]  

  • 34. [What information is given by controlled clinical trials (pharmacological and nonpharmacological) for anti-arrhythmia therapy in the prevention of sudden death?].
    Naccarella F; Croci F
    G Ital Cardiol; 1996 Nov; 26(11):1345-64. PubMed ID: 9036037
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluation of therapeutic modalities in patients with life threatening arrhythmias.
    Teo KK
    Can J Cardiol; 1994 Apr; 10(3):333-8. PubMed ID: 8162531
    [No Abstract]   [Full Text] [Related]  

  • 36. [Management of patients with sustained ventricular arrhythmia: anti-arrhythmia agents or defibrillator?].
    Cappato R; Kuck KH
    Cardiologia; 1996 Feb; 41(2):95-105. PubMed ID: 8674097
    [No Abstract]   [Full Text] [Related]  

  • 37. Antiarrhythmic drugs: past, present and future.
    Roden DM
    J Cardiovasc Electrophysiol; 2003 Dec; 14(12):1389-96. PubMed ID: 14678124
    [No Abstract]   [Full Text] [Related]  

  • 38. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Care of adolescents and young adults with cardiac arrhythmias.
    Zeigler VL
    Prog Cardiovasc Nurs; 1995; 10(1):13-21. PubMed ID: 7770437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ICD therapy: what have we learned from the clinical trials?
    Arya A; Haghjoo M; Sadr-Ameli MA
    Heart Lung Circ; 2006 Feb; 15(1):3-11. PubMed ID: 16473784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.